Semi-synthetic bile acid could be a promising therapeutic option for TH17-mediated intestinal diseases
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. A ...
Tag: Hepatology
HMB supplement trial explores new treatment for chronic liver disease
A dietary supplement used to build muscle – or prevent muscle loss as a result of aging or illness – ...
Evaluating biomarkers for diagnosing minimal hepatic encephalopathy in cirrhotic patients
Background and aims The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin carboxy-terminal ...
Study evaluates effectiveness and safety of TMF for chronic hepatitis B
Background and aims Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for ...
Imbalances in NET homeostasis linked to portal vein thrombosis in CHB-related decompensated cirrhosis
Background and aims Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic ...
HMGB1 as a key mediator in liver disease pathogenesis
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates. Acute ...
Investigating the relationship between COPD and liver disease in alpha-1 antitrypsin deficiency
Background and aims Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant ...
Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B
Background and aims The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) ...
New framework established for defining prebiotics
The concept of prebiotics – defined as substrates that are selectively utilized by host microorganisms conferring a health benefit – ...
Mainz Biomed to unveil breakthrough early cancer detection study results at DDW 2024
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from ...